Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemia
Phase 1
- Conditions
- Digital ischaemia/ulceration in patients with scleroderma-spectrum disorders
- Registration Number
- EUCTR2004-002799-41-GB
- Lead Sponsor
- Salford Royal Hospitals Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
A diagnosis of SSc (or of another scleroderma-spectrum disorder) and severe digital ischaemia and/or digital ulceration severe enough to require hospitalisation for intravenous prostanoid therapy.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Age < 18 or > 80 years. Pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method